Author: Friedman Yali
Publisher: Palgrave Macmillan Ltd
ISSN: 1478-565X
Source: Journal of Commercial Biotechnology, Vol.16, Iss.1, 2010-01, pp. : 1-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A new science-business paradigm in anticancer drug development
Trends in Biotechnology, Vol. 21, Iss. 3, 2003-03 ,pp. :
A new model to evaluate the market for biotechnology
Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. :